The search for strategies to control hypertension

Circulation

Volumn 122, Issue 12, 2010, Pages 1141-1143

  Kotchen, Theodore A ^a  

^a MEDICAL COLLEGE OF WISCONSIN   (United States)

Author keywords

adherence; ambulatory care; compliance; drug therapy; Editorials; hypertension

Indexed keywords

ANTIHYPERTENSIVE AGENT;

AWARENESS; BLOOD PRESSURE REGULATION; CARDIOVASCULAR RISK; DRUG EFFICACY; EDITORIAL; HEALTH PROMOTION; HIGH RISK PATIENT; HUMAN; HYPERTENSION; LIFESTYLE MODIFICATION; MORBIDITY; MORTALITY; OBESITY; PRACTICE GUIDELINE; PRIORITY JOURNAL; PUBLIC HEALTH; SELF CARE; SOCIAL SUPPORT; LIFESTYLE; PATIENT COMPLIANCE; PREVALENCE; SPAIN; TREATMENT OUTCOME; UNITED STATES;

ANTIHYPERTENSIVE AGENTS; HUMANS; HYPERTENSION; LIFE STYLE; PATIENT COMPLIANCE; PREVALENCE; SPAIN; TREATMENT OUTCOME; UNITED STATES;

EID: 77957269292     PISSN: 00097322     EISSN: 15244539     Source Type: Journal    
DOI: 10.1161/CIRCULATIONAHA.110.978759     Document Type: Editorial

References (21)

1. Ezzati M, Lopez AD, Rodgers A, Vander Hoorn S, Murray CJ; Comparative Risk Assessment Collaborating Group. Selected major risk factors and global regional burden of disease. Lancet. 2002;360: 1347-1360.
2. Kearney PM, Whelton M, Reynolds K, Muntner P, Whelton PK, He J. Global burden of hypertension: analysis of worldwide data. Lancet. 2005; 365:217-223.
3. Neal B, MacMahon S, Chapman N. Effects of ACE inhibitors, calcium antagonists, and other blood pressure lowering drugs: results of prospec-tively designed overviews of randomized trials. Blood Pressure Lowering Treatment Trialists' Collaboration. Lancet. 2000;356:1955-1964.
4. Hajjar I, Kotchen TA. Trends in prevalence, awareness, treatment, and control of hypertension in the United States, 1988-2000. JAMA. 2003; 290:199-206.
5. Egan BM, Zhao Y, Axon RN. US trends in prevalence, awareness, treatment, and control of hypertension, 1988-2008. JAMA. 2010;303: 2043-2050.
6. Lenfant C. Shattuck lecture\clinical research to clinical practice\lost in translation? N Engl J Med. 2003;349:868-874.
7. st Century. Washington, DC: National Academy Press; 2001.
8. Berwick DM. Disseminating innovations in health care. JAMA. 2003;289: 1969-1975.
9. Ogedegbe G. Barriers to optimal hypertension control. J Clin Hypertens. 2008;10:644-646.
10. Pladevall M, Brotons C, Gabriel R, Arnau A, Suarez C, de la Figuera M, Marquez E, Coca A, Sobrino J, Divine G, Heisler M, Williams LK, Writing Committee on behalf of the COM99 Study Group. Multicenter cluster-randomized trial of a multifactorial intervention to improve anti-hypertensive medication adherence and blood pressure control among patients at high cardiovascular risk (The COM99 study). Circulation. 2010;122:1183-1191.
11. Glynn LG, Murphy AW, Smith SM, Schroeder K, Fahey T. Interventions used to improve control of blood pressure in patients with hypertension. Cochrane Database of Systematic Reviews 2010, Issue 3. Art. No.: CD005182. DOI: 10.1002/14651858.CD005182.pub4.
12. Brownstein JN, Chowdhury FM, Norris S, Horsley T, Jack L Jr, Zhang X, Satterfield D. Effectiveness of community health workers in the care of people with hypertension. Am J Prev Med. 2007;32:435-447.
13. Kirchhoff AC, Drum ML, Zhang JX, Schlichting J, Levie J, Harrison JF, Lippold SA, Schaefer CT, Chin MH. Hypertension and hyperlipidemia management in patients treated at community health centers. J Clin Outcomes Manag. 2008;15:125-131.
14. The Patient Protection and Affordable Care Act. U.S. Government Printing Office Web site. http://www.gpo.gov/fdsys/pkg/PLAW-111publ148/html/PLAW- 111publ148.htm. Accessed August 13, 2010.
15. Scisney-Matlock M, Bosworth HB, Giger JN, Strickland OL, Harrison RV, Coverson D, Shah NR, Dennison CR, Dunbar-Jacob JM, Jones L, Ogedegbe G, Batts-Turner ML, Jamerson KA. Strategies for implementing and sustaining therapeutic lifestyle changes as part of hypertension management in African Americans. Postgrad Med. 2009;121: 147-159.
16. Kotchen JM, McKean HE, Jackson-Thayer S, Moore RW, Straus R, Kotchen TA. Impact of a rural high blood pressure control program on hypertension control and cardiovascular disease mortality. JAMA. 1986; 255:2177-2182.
17. Fulwood R, Guyton-Krishnan J, Wallace M, Sommer E. Role of community programs in controlling blood pressure. Current Hypertension Reports. 2006;8:512-520.
18. Paschal AM, Lewis RK, Martin A, Shipp DD, Simpson DS. Evaluating the impact of a hypertension program for African Americans. J Natl Med Assoc. 2006;98:607-615.
19. Papadakis S, Moroz I. Population-level interventions for coronary heart disease prevention: what have we learned since the North Karelia project? Curr Opin in Cardiol. 2008;23:452-461.
20. Must A, Spadano J, Coakley EH, Field AE, Colditz G, Dietz WH. The disease burden associated with overweight and obesity. JAMA. 1999;282: 1523-1529.
21. Mokdad AH, Ford ES, Bowman BA, Dietz WH, Vinicor F, Bales VS, Marks JS. Prevalence of obesity, diabetes, and obesity-related health risk factors, 2001. JAMA. 2003;289:76-79.